NUVATION BIO INC (NUVB) Stock Income Statement
NYSE:NUVB - New York Stock Exchange, Inc. - US67080N1019 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.96M | 7.87M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 9.17M | 7.08M | N/A | N/A | N/A | |||
| Gross Profit | 1.78M | 795.00K | N/A | N/A | N/A | |||
| Operating Expenses | 208.15M | 168.35M | 99.82M | 112.33M | 93.32M | |||
| Research and Development | 110.88M | 99.12M | 71.29M | 80.52M | 69.04M | |||
| Selling, General, and Administrative Expenses | 97.27M | 69.23M | 28.53M | 31.82M | 24.28M | |||
| Operating Income | -206.36M | -167.56M | -99.82M | -112.33M | -93.32M | |||
| Interest Income/Expense | 24.85M | 26.71M | 24.47M | 6.22M | 2.88M | |||
| Other Income/Expense | 201.00K | -2.02M | -452.00K | 9.32M | 3.59M | |||
| Non Recurring Items | N/A | -425.07M | N/A | -7.40M | N/A | |||
| Income Before Taxes | -606.38M | -567.94M | -75.80M | -104.20M | -86.85M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -606.38M | -567.94M | -75.80M | -104.20M | -86.85M | |||
| EBITDA | -205.43M | -166.87M | -99.60M | -112.13M | -93.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.34 | -2.11 | -0.35 | -0.48 | -0.44 | |||
| Non GAAP EPS | -0.61 | -0.52 | -0.34 | -0.48 | -0.44 | |||
| Statistics | ||||||||
| Gross Profit Margin | 16.29% | 10.10% | N/A | N/A | N/A | |||
| Profit Margin | -5534.21% | -7213.76% | N/A | N/A | N/A | |||
| Operating Profit Margin | -1883.38% | -2128.25% | N/A | N/A | N/A | |||
All data in USD